Satisfaction With Hormonal Treatment for Menstrual Suppression in Adolescents and Young Women With Disabilities
- PMID: 33712384
- DOI: 10.1016/j.jadohealth.2021.01.031
Satisfaction With Hormonal Treatment for Menstrual Suppression in Adolescents and Young Women With Disabilities
Abstract
Purpose: To characterize the population of adolescents and young women with special needs presenting for gynecologic care, describe usage patterns of hormonal suppression methods, and evaluate outcomes of menstrual management.
Methods: This retrospective cohort study included females with special needs up to age 26 years presenting for menstrual management from 2009 to 2018. Demographic, social, and medical histories were collected to investigate effects on bleeding pattern and satisfaction with menstrual management.
Results: Of 262 patients who presented for menstrual complaints, final methods of treatment included combined hormonal contraceptives (30.9%), oral progestins (19.8%), depot medroxyprogesterone acetate (8.0%), etonogestrel implant (1.9%), and levonorgestrel intrauterine device (16.8%). Eighty-five percent of patients were satisfied with their final bleeding pattern. Patients with amenorrhea or light regular periods were more likely to be satisfied than patients with heavy or irregular bleeding (p < .001). Satisfied patients tried an average of 1.4 methods, compared to 1.8 methods tried by the unsatisfied group (p = .042). By the end of the study, 26.0% were amenorrheic and 12.8% had only light spotting. Satisfaction rates were similar with each method, including 88.4% with use of combined hormonal contraceptives, 82.5% with oral progestins, 93.3% with depot medroxyprogesterone acetate, 100% with etonogestrel implant, and 83.9% with levonorgestrel intrauterine device.
Conclusions: Amenorrhea or light regular bleeding led to satisfaction in most patients. No hormonal method was superior. When counseling families and patients who present for menstrual suppression, emphasis should be placed on goals of treatment and expectations for outcomes, as light regular periods may be as acceptable as amenorrhea.
Keywords: Adolescent gynecology; Cognitive disability; Developmental delay; Menstrual management; Menstrual suppression.
Copyright © 2021 Society for Adolescent Health and Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Menstrual Suppression in Pediatric and Adolescent Patients with Disabilities Ranging from Developmental to Acquired Conditions: A Population Study in an Australian Quaternary Pediatric and Adolescent Gynecology Service from January 2005 to December 2015.J Pediatr Adolesc Gynecol. 2019 Oct;32(5):535-540. doi: 10.1016/j.jpag.2019.05.005. Epub 2019 Jun 8. J Pediatr Adolesc Gynecol. 2019. PMID: 31181330
-
Bleeding changes after levonorgestrel 52-mg intrauterine system insertion for contraception in women with self-reported heavy menstrual bleeding.Am J Obstet Gynecol. 2020 Apr;222(4S):S888.e1-S888.e6. doi: 10.1016/j.ajog.2019.11.1288. Epub 2019 Dec 19. Am J Obstet Gynecol. 2020. PMID: 31866516
-
Preparing for Puberty in Girls With Special Needs: A Cohort Study of Caregiver Concerns and Patient Outcomes.J Pediatr Adolesc Gynecol. 2021 Aug;34(4):471-476. doi: 10.1016/j.jpag.2021.03.008. Epub 2021 Apr 7. J Pediatr Adolesc Gynecol. 2021. PMID: 33838332
-
General Approaches to Medical Management of Menstrual Suppression: ACOG Clinical Consensus No. 3.Obstet Gynecol. 2022 Sep 1;140(3):528-541. doi: 10.1097/AOG.0000000000004899. Obstet Gynecol. 2022. PMID: 36356248
-
Vaginal bleeding patterns in women using once-a-month injectable contraceptives.Contraception. 1994 Apr;49(4):399-420. doi: 10.1016/0010-7824(94)90035-3. Contraception. 1994. PMID: 8013222 Review.
Cited by
-
Reproductive healthcare in adolescents with autism and other developmental disabilities.Am J Obstet Gynecol. 2024 May;230(5):546.e1-546.e14. doi: 10.1016/j.ajog.2024.01.005. Epub 2024 Jan 12. Am J Obstet Gynecol. 2024. PMID: 38218512 Free PMC article.
-
Gynecological care needs for young women with spina bifida.Health Care Transit. 2023 Apr 29;1:100002. doi: 10.1016/j.hctj.2023.100002. eCollection 2023. Health Care Transit. 2023. PMID: 39712996 Free PMC article. No abstract available.
-
Contraceptive Provision to Women With Intellectual and Developmental Disabilities Enrolled in Medicaid.Obstet Gynecol. 2023 Dec 1;142(6):1477-1485. doi: 10.1097/AOG.0000000000005421. Epub 2023 Oct 26. Obstet Gynecol. 2023. PMID: 38051293 Free PMC article.
-
Contraception in adolescents with mental disorders: adherence and satisfaction in the use of depot medroxyprogesterone acetate.Rev Bras Ginecol Obstet. 2025 Mar 17;47:e-rbgo9. doi: 10.61622/rbgo/2025rbgo9. eCollection 2025. Rev Bras Ginecol Obstet. 2025. PMID: 40242009 Free PMC article.
-
Reversible interventions for menstrual management in adolescents and young adults with gender incongruence.Ther Adv Reprod Health. 2023 Mar 14;17:26334941231158251. doi: 10.1177/26334941231158251. eCollection 2023 Jan-Dec. Ther Adv Reprod Health. 2023. PMID: 36938373 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical